Skip to main content
. 2011 Jul 6;2011(7):CD006207. doi: 10.1002/14651858.CD006207.pub4

Turner 2004b.

Methods Double‐blind, randomised controlled trial conducted by Hill Top Research, Inc. Winnipeg, Canada, to assess the residual virucidal activity of a skin cleanser wipe and its effectiveness in preventing experimental rhinovirus colds. Subjects in good health and from 18 to 60 were recruited from Winnipeg and surrounding communities for participation
 The residual activity of a skin cleanser wipe containing 4% pyroglutamic acid formulated with 0.1% benzalkonium chloride was tested. The negative control treatment was 62% ethanol. Benzalkonium chloride had been previously tested and was found to have no virucidal activity. Volunteers were randomly assigned to use the control preparation or the active preparation. The study material was applied to hands with a towelette. Fifteen minutes later, when the fingers were completely dry, the fingertips of each hand of the control subjects and the volunteers in the active treatment group were contaminated with rhinovirus type 39. An additional volunteer in the active group were challenged with virus 1 hour after application and the final group of volunteers was challenged 3 hours after application. Viral infection was assessed by culture of nasal lavage specimens and blood samples
Participants 122 volunteers, 30 control group, 92 active group (30 tested after 15 minutes, 30 after 1 hour, 32 after 2 hours)
Interventions Use of a skin cleanser wipe containing 4% pyroglutamic acid formulated with 0.1% benzalkonium chloride versus skin cleanser wipe containing ethanol
Outcomes Laboratory: yes
 Effectiveness: rhinovirus type 39 infection
 Safety: N/A
Notes Risk of bias: unclear (no description of randomisation process, concealment or allocation)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomised"
Sequence generation not described
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection bias) 
 All outcomes Unclear risk "double blind" but no description given
Incomplete outcome data (attrition bias) 
 All outcomes Low risk All accounted for (short study)
Selective reporting (reporting bias) High risk Poorly reported